Omeros
OMER • NASDAQ
Omeros is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gregory A. Demopulos, with a market cap of $761.5M.
CEOGregory A. Demopulos
Market Cap$761.5M
Biotechnology
Healthcare
Employees198.0
Websiteomeros.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Omeros
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.12
Revenue Estimate
$1.6M
Earnings History
Past 12 earnings reports for Omeros
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.34Est: -$0.52 | +34.6% | -Est: $312.5K | -100.0% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.43Est: -$0.55 | +21.8% | -Est: $312.5K | -100.0% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.58Est: -$0.60 | +3.3% | -Est: $400.0K | -100.0% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.63Est: -$0.71 | +11.3% | - | — | 10-K/A |
| Nov 13, 2024 | Q3 2024 | -$0.64Est: -$0.70 | +8.6% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.97Est: -$0.69 | -40.6% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.63Est: -$0.58 | -8.6% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.63Est: -$0.55 | -14.5% | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$0.60 | — | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.59Est: -$0.57 | -3.5% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.54Est: -$0.56 | +3.6% | - | — | 10-Q |
| Mar 13, 2023 | Q4 2022 | -$0.73Est: -$0.56 | -30.4% | - | — | — |